MedCheck: FDA Approves Novel Antipsychotic Milsaperidone; Designates Psilocybin Analogue as Breakthrough Therapy for Postpartum Depression, and More
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Fields of Study & Subjects
Maternal Mental Health During Pregnancy and Postpartum
Treatment of Major Depression
Psychedelics and Drug Studies
Publication details
- Journal / source
- Psychiatric News
- Volume
- 61
- Issue
- 4
- Publication date
- 30 March 2026
- Language
- EN